Equity

Stockholders' Equity Note, Subscriptions Receivable

Analysis

StatementBalance Sheet Statement
SectionEquity
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: equity_stockholders_equity_note_subscriptions_receivable

Historical Data

2 periods
 Q4 '25Q1 '26
Value$0.00$1.23M
Range$0.00 – $1.23M

Frequently Asked Questions

What is Veradermics 's stockholders' equity note, subscriptions receivable?
Veradermics (MANE) reported stockholders' equity note, subscriptions receivable of $1.23M in Q1 2026.